triazolam has been researched along with ergoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connell, TA; Weiss, B; Welsh, S; Zhang, SP; Zhou, LW | 1 |
| Granier, J; Hucher, M; Klein, MJ; Patat, A; Surjus, A | 1 |
1 trial(s) available for triazolam and ergoline
| Article | Year |
|---|---|
Study of the potential reversal of triazolam memory and cognitive deficits by RU 41 656 in healthy subjects.
Topics: Adult; Attention; Cognition Disorders; Double-Blind Method; Emotions; Ergolines; Flicker Fusion; Humans; Male; Memory; Memory Disorders; Psychomotor Performance; Reaction Time; Receptors, Dopamine; Receptors, Dopamine D2; Reference Values; Triazolam | 1991 |
1 other study(ies) available for triazolam and ergoline
| Article | Year |
|---|---|
Triazolam blocks the initial rotational effects of quinpirole but permits the later developing reduction of dopamine D2-mediated rotational behavior and dopamine D2 receptors.
Topics: Analysis of Variance; Animals; Dopamine Agents; Down-Regulation; Ergolines; gamma-Aminobutyric Acid; Male; Mice; Motor Activity; Quinpirole; Receptors, Dopamine D2; Sulpiride; Triazolam | 1992 |